Niagen Bioscience, Inc.
Niagen Bioscience, Inc.
LOS ANGELES, CA
Loading...
Price History
Market Data
| Market Cap | 945,000.00 |
| P/E Ratio | - |
| P/B Ratio | 0.01 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.39 |
| Current Ratio | 4.86 |
| Currency | USD |
Key Financial Metrics
129.42M
Revenue
17.38M
Net Income
-
EPS (Diluted)
30.52M
Free Cash Flow
Profitability
Gross Margin
64.3%
Operating Margin
12.6%
Net Profit Margin
13.4%
EBITDA
16.28M
Returns & Efficiency
Return on Assets (ROA)
16.3%
Return on Equity (ROE)
22.7%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
106.41M
Total Debt
-
Debt to Equity
0.39x
Current Ratio
4.86
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | LOS ANGELES, CA |
| Fiscal Year | 2025 |
Peers
TRULIEVE CANNABIS CORP.
TCNNF
2.31B
P/E: --
CRONOS GROUP INC.
CRON
1.44B
P/E: --
TILRAY, INC.
TLRY
667.99M
P/E: --
TILRAY BRANDS, INC.
TLRY
667.99M
P/E: --
Tilray Brands, Inc.
TLRY
667.99M
P/E: --
654.42M
P/E: --
352.53M
P/E: 29.2
237.70M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$945.00K
P/E Ratio (TTM)-
Price to Book0.01
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin64.3%
Operating Margin12.6%
Net Margin13.4%
ROE22.7%
ROA16.3%
Leverage & Liquidity
Debt to Equity0.39
Current Ratio4.86
Total Debt-
Total Assets$106.41M
Stockholders' Equity$76.53M
Income Statement (FY 2025)
Revenue$129.42M
Gross Profit$83.19M
Operating Income$16.28M
Net Income$17.38M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$30.52M
Cash & Equivalents-
Revenue Growth29.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES, CA 90024 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 262940963 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 225,000.00 |
| Stockholders' Equity | $76.53M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-29
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-29
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-19
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-04
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-04
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-04
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-06
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Niagen Bioscience, Inc. |
| Ticker | NAGE |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | LOS ANGELES, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 945,000.00 |
| Revenue | 129.42M |
| Net Income | 17.38M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 13.4% |
| ROE | 22.7% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...